Trans-10,cis-12 conjugated linoleic acid (CLA) supplementation causes milk fat depression in dairy cows, but CLA effects on glucose metabolism are not clear. The objective of the study was to investigate glucose metabolism, especially endogenous glucose production (eGP) and glucose oxidation (GOx), as well as hepatic genes involved in endogenous glucose production in Holstein cows supplemented either with 50 g of rumen-protected CLA (9% trans-10,cis-12 and 10% cis-9,trans-11; CLA; n = 10) or 50 g of control fat (24% C18:2; Ctrl; n = 10) from wk 2 before parturition to wk 9 of lactation. Animal performance data were recorded and blood metabolites and hormones were taken weekly from 2 wk before to 12 wk after parturition. During wk 3 and 9 after parturition, glucose tolerance tests were performed and eGP and GOx were measured by [U-13 C] glucose infusion. Liver biopsies were taken at the same time to measure total fat and glycogen concentrations and gene expression of pyruvate carboxylase, cytosolic phosphoenolpyruvate carboxykinase, glucose-6-phosphatase, and carnitine palmitoyl-transferase 1. Conjugated linoleic acid feeding reduced milk fat, but increased milk lactose output; milk yield was higher starting 5 wk after parturition in CLA-fed cows than in Ctrl-fed cows. Energy balance was more negative during CLA supplementation, and plasma concentrations of glucose were higher immediately after calving in CLAfed cows. Conjugated linoleic acid supplementation did not affect insulin release during glucose tolerance tests, but reduced eGP in wk 3, and eGP and GOx increased with time after parturition. Hepatic gene expression of cytosolic phosphoenolpyruvate carboxykinase tended to be lower in CLA-fed cows than in Ctrl-fed cows. In spite of lower eGP in CLA-fed cows, lactose out-put and plasma glucose concentrations were greater in CLA-fed cows than in Ctrl-fed cows. This suggests a CLA-related glucose sparing effect most likely due to lower glucose utilization for milk fat synthesis and probably because of a more efficient whole-body energy utilization in CLA-fed cows.
INTRODUCTION
High-yielding dairy cows are not able to compensate completely for the energy lost due to milk production during early lactation by a sufficient increase of feed intake (Bell and Bauman, 1997; Drackley et al., 2001; Kokkonen et al., 2005) . This leads to the mobilization of body reserves resulting in a negative energy balance that may be associated to health problems. In turn, this can negatively affect animal welfare and profitability of milk production (Bauman, 2000; Drackley et al., 2001; Eastridge, 2006) . One possibility to reduce milk energy output in dairy cows is the decrease of milk fat content by feeding rumen-protected conjugated linoleic acid (CLA), in particular the trans-10,cis-12 CLA isomer (Baumgard et al., 2000; Bauman et al., 2008) . Reports on CLA-induced alterations of macronutrient and energy metabolism in cows are inconsistent, and CLA effects may depend on the dietary status and the stage of lactation of the investigated cows (Bauman and Griinari, 2003; Selberg et al., 2004; Castañeda-Gutiérrez et al., 2005; Odens et al., 2007) . Concerning glucose metabolism, CLA elevated plasma glucose concentrations in one study (Odens et al., 2007) , but, in general, investigations on glucose metabolism with respect to CLA supplementation in dairy cows are limited to glucose concentrations in blood plasma and insulin responses (Bauman et al., 2008) . However, it is unknown if CLA supplementation in dairy cows also changes glucose turnover.
Availability of glucose in the mammary gland is essential for high lactose production and, thus, milk production in dairy cows (Drackley et al., 2001; Brockman, 2259 2005) because lactose is the major osmoregulator for mammary uptake of water (Linzell, 1972; Rigout et al., 2002) . In ruminants, very little glucose originates from net portal absorption, and endogenous glucose production (eGP); that is, the sum of gluconeogenesis and glycogenolysis, provides most of the glucose for milk production (Danfaer, 1994; Bell and Bauman, 1997; Brockman, 2005; Aschenbach et al., 2010) . Therefore, hepatic glucose production strongly increases after calving in dairy cows to provide glucose (Danfaer, 1994; Bell and Bauman, 1997; Brockman, 2005; Aschenbach et al., 2010) . However, it is not known if CLA supplementation affects eGP as well as glucose oxidation (GOx) in high-yielding dairy cows during early lactation. As feeding trans-10,cis-12 CLA reduces milk fat synthesis, and glucose is needed for milk fat synthesis (Grummer and Carroll, 1991; Bauman and Griinari, 2003) , we tested the hypothesis that CLA supplementation may decrease eGP and affect hepatic gene expression of enzymes involved in eGP and hepatic FA oxidation to explain lower glucose use due to reduced milk fat synthesis. Therefore, the objective of this study was to quantify in vivo eGP and GOx, as well as hepatic mRNA abundance of enzymes involved in gluconeogenesis and FA oxidation of CLA-supplemented dairy cows.
MATERIALS AND METHODS

Animals and Feeding
All experimental procedures were carried out according to German animal protection law and approved by the relevant authorities of the state Mecklenburg-Vorpommern, Germany. Twenty Holstein cows with comparable milk production (first lactation >9,000 kg of milk in 305 d) from the research herd of the Leibniz Institute for Farm Animal Biology (FBN), Dummerstorf, or purchased from a local farm, were kept in a tie stall and were randomly allocated to 2 groups before the beginning of their second lactation.
Cows were fed ad libitum a TMR supplemented with either with 50 g/d of Lutrell pure (BASF, Ludwigshafen, Germany) containing 9.3% trans-10,cis-12 and 10.3% cis-9,trans-11 CLA isomers (CLA; n = 10), or 50 g/d of control fat (BASF; Ctrl; n = 10; Table 1 ). Both fat types were provided in a rumen-protected form. Conjugated linoleic acid supplementation lasted from 2 wk before estimated calving date to wk 9 of lactation (supplementation period). From wk 10 to 12 in both groups, fat supplementation was removed from the ration (depletion period); the experiment was terminated at wk 12 of lactation. Cows were investigated in 5 blocks consisting of 4 cows in each block (2 Ctrl and 2 CLA cows) from July 2009 to August 2010. Cows did not suffer from clinical diseases such as metritis, milk fiber, ketosis, or displaced abomasum. When mastitis occurred, cows were treated with antibiotics and milk data during clinical mastitis were removed from data analyses.
Cows had free access to water. Individual feed intake was recorded daily. Feed samples (TMR, corn and grass silage) were pooled weekly, stored at −20°C until analyzed according to Naumann and Bassler (2004) at the Agricultural Faculty of the University of Rostock and at the Landwirtschaftliche Untersuchungs-und Forschungsanstalt (LUFA, Rostock, Germany). Ingredients and chemical composition for the close-up (wk 2-0 before parturition) and lactation diet (wk 1-12 of lactation) are shown in Table 2 . Cows were milked twice daily and milk samples were taken once weekly for measurement of fat, lactose, and protein in milk at the Landeskontrollverband für Leistungs-und Qualitätsprüfung Mecklenburg-Vorpommern e.V. (Güstrow, Germany). In milk samples collected in wk 3 and 9 of lactation, FA pattern was determined at the Lehrstuhl für Tierzucht, Technische Universität München (Kranzberg, Germany) as described (Sigl et al., 2010) . Energycorrected milk and energy balance were calculated as described . Body weight, BCS, and back fat thickness (BFT) were recorded weekly (Duske et al., 2009) .
Metabolites and Hormones
Blood samples were taken by jugular venipuncture (Vacuette, Greiner Bio One International, Kremsmünster, Austria) once weekly (day relative to calving ± 1 d tolerance) after the morning milking and before cows were allowed to eat. Tubes either contained anticoagulants dipotassium-EDTA (1.8 mg/mL of blood) and sodium fluoride (3 mg/mL of blood) for triglycerides, NEFA, BHBA, cholesterol, glucose, and urea analyses, and potassium-EDTA (1.8 mg/mL of blood) for insulin and glucagon analyses in blood plasma. Blood samples were kept on ice before centrifugation at 4°C and 1,500 × g for 20 min. Plasma aliquots were stored at −20°C until analyses. Plasma metabolites were analyzed with an automatic analyzer (Pentra 400, Axon Lab, Reichenbach, Germany) at the clinic for cattle at the Stiftung Tierärztliche Hochschule (Hannover, Germany). Measurements of plasma concentrations of glucose and cholesterol were performed with kits from Idstein, Germany) . Triglycerides, urea, BHBA, and NEFA concentrations were analyzed using kits no. A11A01640, no. LT-UR 0050, no. RB 1008, and no. 434-91795 from Horiba Europe GmBH (Hannover, Germany), Lehmann (Berlin, Germany), Randox Laboratories (Crumlin, UK), and Wako Chemicals GmbH (Neuss, Germany), respectively. Plasma insulin concentrations were analyzed by RIA as described before (Hammon and Blum, 1998) . Plasma glucagon concentrations were measured by RIA using a kit from Linco (GL-32K, Linco Research, St. Charles, MO; Hammon et al., 2009) .
Glucose Tolerance Test
A glucose tolerance test (GTT) was performed at the beginning of wk 3 and 9 of lactation, respectively. After overnight food withdrawal, cows were fitted with jugular catheters (Cavafix Certo 338, Braun, Melsungen, Germany) for infusion of a glucose bolus (1 g/kg 0.75 ; . Blood samples for determination of plasma glucose and insulin concentrations were collected 15 and 5 min before, and 5, 10, 15, 20, 45, 60, and 120 min after glucose infusion in tubes containing 1.6 mg of potassium-EDTA/mL of blood (Monovette, Sarstedt AG, Nürnberg, Germany) and were put on ice until centrifuged at 1,500 × g for 20 min at 4°C. Plasma aliquots were stored at −20°C until analyzed for glucose and insulin as described above.
eGP and GOx
Three days after GTT at wk 3 and 9 of lactation, respectively, eGP and GOx were determined after overnight food withdrawal using a primed continuous intravenous infusion of [U-13 C]-glucose [99 atom% 13 C, Eurisotop, Staint Aubin, Cedex, France; prime: 5.4 μmol/kg; infusion: 7.5 μmol/(kg × h)] for 4 h (Hammon et al., 2008; Steinhoff-Wagner et al., 2011) . Cows were fitted with 2 jugular catheters (Cavafix Certo 338) for tracer infusion and blood sampling. Blood samples were collected 10 and 5 min before tracer infusion and at 10, 30, 60, 90, 120, 150, 180, 210 , and 240 min after start of infusion in tubes containing Li-heparin (14 to 15 IU/mL; S-Monovette, Sarstedt, Nürnberg, Germany). Enrichment of [U-13 C]-glucose was determined by GC-MS (QP2010, coupled with GC 2010; Shimadzu, Duisburg, Germany) as recently described (Hammon et al., 2008; Steinhoff-Wagner et al., 2011) . Whole blood in potassium-EDTA tubes collected before and at regular intervals between 10 to 240 min after start of tracer infusion was used to isolate CO 2 , to measure its 13 C/ 12 C Concentrate MLF 2000 (Vollkraft Mischfutterwerke GmbH, Güstrow, Germany) consisted of (g/kg of DM) 330 g of soy, 200 g of corn, 170 g of wheat gluten, 130 g of wheat, 80 g of rape seed expeller, 50 g of low sugar beet pulp chips, calcium (0.13 mol; 5.2 g), sodium (0.42 mol; 9.65 g), chloride (0.03 mol; 1.2 g). 3 Concentrate Universal 18/3 (Vollkraft Mischfutterwerke GmbH) consisted of (g/kg of DM) 200-400 g of cereals (triticale, rye, wheat, barley), <250 g of rapeseed expeller, malt germs, wheat gluten, wheat bran, peeled oat-bran, beet pulp chips, molasses, glycerin, calcium (0.19 mol; 7.5 g), phosphorus (0.18 mol; 5.5 g), sodium (0.09 mol; 2 g), retinol (9.66 μmol; 2.4 mg), β-carotene (8.95 μmol; 4.8 mg), 25-OHvitamin D 3 (0.05 μmol; 22.5 μg). 4 Mineral supplements in close-up feeding: Anionen-Mix 1141 (Salvana, Sparrieshoop, Germany), g/kg of DM: calcium (3.5 mol; 140 g), sulfur (3.9 mol; 125 g), chlorine (3.4 mol; 120 g), magnesium (4.1 mol; 100 g), phosphorus (0.65 mol; 20 g), retinol (0.48 mmol; 0.12 g), β-carotene (0.45 mmol; 0.24 g), 25-OH-vitamin D 3 (3 μmol; 1.25 mg), dl-αtocopherolacetate (8.5 mmol; 4 g).
5
Mineral supplements in lactation feeding: Rinderstolz 9522 (Salvana), g/kg of DM: calcium (5 mol; 200 g), phosphorus (1.6 mol; 50 g), magnesium (2.5 mol; 60 g), sodium (3.5 mol; 80 g), retinol (1.2 mmol; 0.3 g), β-carotene (1.1 mmol; 0.6 g), 25-OH-vitamin D 3 (12 μmol; 5 mg), dl-α-tocopherolacetate (9.5 mmol; 4.5 g). 6 German Society of Nutrition Physiology (2001). by ratio by mass spectrometry, and to calculate GOx (Hammon et al., 2008) .
Analyses in Liver
Liver biopsies were taken at the end of wk 3 and 9 of lactation, respectively, immediately frozen in liquid nitrogen, and stored at −80°C until analyzed (Duske et al., 2009) . Liver tissue was homogenized and glycogen concentration in liver was determined with a commercial photometric test kit based on amyloglucosidasecatalyzed release of glucose (no. 10207748035; Boehringer Mannheim/R-Biopharm, Mannheim, Germany). Measurement of liver fat concentrations was performed as described (Kuhla et al., 2004) .
Transcript levels were determined for pyruvate carboxylase (PC; EC 6.4.1.1), cytosolic phosphoenolpyruvate carboxykinase (PEPCKc; EC 4.1.1.32), glucose-6-phosphatase (G6Pase; EC 3.1.3.9), and carnitine palmitoyl-transferase 1(CPT 1; EC 2.3.1.21) by the LightCycler Real-Time PCR System (Roche Applied Science, Mannheim, Germany), using SYBR Green I as detection format (Pfaffl, 2001; Hammon et al., 2009 ). Glyceraldehyde-3-phosphate dehydrogenase was used as a reference gene because it was not affected by diet and time. Primer sequences were recently published van Dorland et al., 2009 ). Melting temperatures were checked for specificity of each product. Gel electrophoresis of the PCR product demonstrated only one single band of the expected size. Products were verified by sequencing using an ABI Sequencing kit (ABI Big Dye Terminator, Applied Biosystems, Darmstadt, Germany) and an ABI 310 Genetic Analyzer (Applied Biosystems). Relative quantification of mRNA concentrations was performed as described (Pfaffl, 2001; Hammon et al., 2009) . Efficiencies of PCR were >1.8, and inter-and intra-assay CV for reverse transcription-PCR were <1%, respectively.
Statistical Analyses
Data are presented as LSM ± SEM. For data measured daily, such as DMI and milk yield, data were condensed to weekly means for statistical analyses. For glucose and insulin plasma concentrations during GTT, the area under the curve (AUC; AUC gluc and AUC ins , respectively) was calculated using the Graph-Pad computer program (GraphPad Software Inc., San Diego, CA). Basal concentrations were subtracted to calculate net AUC. Performance, metabolic, and hormone data, as well as eGP, GOx, AUC, and liver data were analyzed by the MIXED procedure (SAS/STAT 9.2, 2009; SAS Institute Inc., Cary, NC) with diet, time of blood sampling, and diet × time interaction as fixed effects, and individual cows as random effect. Differences were localized by Tukey t-test. For performance, metabolic, and hormone data, data were evaluated for treatment and time effects during supplementation and depletion periods separately. Data were considered significantly different when P < 0.05 and trends were discussed when P ≤ 0.15.
RESULTS
Animal Performance
After parturition, DMI increased (P < 0.01) in both groups with time, and tended to be lower (P = 0.15) in CLA-fed cows than in Ctrl-fed cows (Table 3) . Body weight decreased in both groups around parturition (P < 0.01) until wk 4 of lactation and tended to be higher before parturition (interaction P = 0.07) in Ctrl-fed than in CLA-fed cows (Table 3) . Back fat thickness and BCS decreased (P < 0.01) in both groups with onset of lactation (Table 3) . Milk yield increased slightly more in Ctrl-fed than in CLA-fed cows, but after wk 5 of lactation milk yield was higher in CLA-fed than in Ctrlfed cows (interaction P < 0.01; Figure 1A ). Energycorrected milk showed time effects (P < 0.01) for both groups (Table 3) . As expected, CLA supplementation reduced milk fat concentration (P < 0.01) and milk fat yield (P < 0.01) by 14 and 13%, respectively ( Figure  1B and C). After termination of CLA supplementation, both milk fat concentration and yield increased (P < 0.01) in CLA-fed cows, and milk fat concentration-but not yield-was still lower (P < 0.05) in CLA-fed than Ctrl-fed cows. Milk protein concentration and protein yield peaked (P < 0.01) at 3 wk, whereas milk urea tended to peak (P < 0.1) at 4 wk of lactation and then all decreased in both groups (Table 3) . Lactose concentration and yield increased (P < 0.01) after the onset of lactation, and lactose yield was higher (P < 0.05) during CLA supplementation and tended to be higher (P < 0.1) during depletion period in CLA-fed than in Ctrl-fed cows (Table 3) . Energy balance decreased (P < 0.05) with onset of lactation, but increased (P < 0.01) after wk 2 of lactation until the end of the study in both groups, and was higher (P < 0.05) during supplementation in Ctrl-than CLA-fed cows (Table 3) .
In milk fat, concentrations of most of the short-and medium-chain FA (C4:0-C16:0) were lower (P < 0.05 or less) in CLA-fed than Ctrl-fed cows (Table 4 ). Stearic and oleic acid in milk fat were higher (P < 0.05) in CLA-fed than Ctrl-fed cows. Concentration of trans-10,cis-12 CLA was higher (P < 0.05) in CLA-fed than Ctrl-fed cows, whereas the cis-9,trans-11 CLA isomer did not differ between groups. 
Metabolites and Hormones
Cows receiving CLA showed elevated plasma concentrations of glucose ( Figure 2 ) from wk 1 to 5 of lactation (interaction P < 0.01). Plasma concentrations of NEFA, BHBA, cholesterol, glucagon, and the glucagon to insulin ratio increased (P < 0.01); whereas plasma concentrations of triglycerides and insulin decreased (P < 0.01) with onset of lactation (Table 5 ). Plasma concentrations of cholesterol tended to increase more steeply in CLA-than in Ctrl-fed cows (interaction: P < 0.15; Table 5 ). Plasma triglyceride concentrations increased (interaction: P < 0.15) during wk 10 of lactation in CLA-fed cows-after termination of CLA supplementation-but not in Ctrlfed cows. Plasma urea concentrations increased (P < 0.05) from wk 4 of lactation in Ctrl-fed cows and from wk 5 in CLA-fed cows and urea concentrations tended to be lower (P < 0.15) during supplementation in CLA-fed than Ctrl-fed cows (Table 5) .
eGP, GOx, and GTT
Endogenous glucose production and GOx increased (P < 0.01) with time during lactation, and in wk 3 eGP was lower (P < 0.05) in CLA-fed than Ctrl-fed cows (Table 6 ). Basal plasma glucose concentration increased from wk 3 to 9 (Table 6 ). Plasma glucose and insulin concentrations increased after glucose infusion during GTT in wk 3 and 9 (P < 0.01), and insulin secretion based on AUC tended to increase with time in CLA-fed cows, but not in Ctrl-fed cows (interaction; P < 0.15; Table 6 ).
Measurements in Liver
Total fat concentrations in liver were higher (P < 0.05) in wk 3 than in wk 9 of lactation (Table 7) . Hepatic glycogen concentrations did not differ with respect to CLA supplementation and time. Gene expression of Samples were collected in wk 3 and wk 9 of lactation from cows supplemented with CLA and control fat (Ctrl), fed from 2 wk before parturition up to wk 9 of lactation. PEPCKc and G6Pase tended to be lower (P < 0.1 and P < 0.15) in CLA-fed than in Ctrl-fed cows (Table 7) .
DISCUSSION
Effects of CLA on Milk Performance and Body Condition
Extent of milk fat reduction during CLA supplementation corresponds to previous studies (Baumgard et al., 2000; Selberg et al., 2004; Castañeda-Gutiérrez et al., 2005) . Milk fat concentration became significantly lower in CLA-than in Ctrl-fed cows after wk 2 of lactation, although CLA feeding started 2 wk before parturition. The delay in milk fat depression is in line with previous studies (Bernal-Santos et al., 2003; Castañeda-Gutiérrez et al., 2005; Odens et al., 2007) and is probably induced by peripartal processes, because during established lactation milk fat depression occurs shortly after commencing CLA supplementation (Giesy et al., 2002 , Perfield et al., 2002 . Milk fat contained the trans-10,cis-12 CLA isomer at wk 3 of lactation and, therefore, it was transferred to the mammary gland during early lactation. As suggested, the trans-10,cis-12 CLA isomer predominantly inhibits de novo FA synthesis in the mammary gland (Bauman and Griinari, 2003; Peterson et al., 2003; Odens et al., 2007) . However, milk fat during early lactation may contain more long-chain FA derived from body fat mobilization rather than newly synthesized FA. We observed a lower proportion of short-and medium-chain FA in milk fat, which seems to support the notion that CLA-related depression of milk fat is due to reduced de novo FA synthesis. However, according to Bauman et al. (2008) , milk fat depression induced by trans-10,cis-12 CLA inhibits both de novo synthesis and milk fat synthesis from preformed FA. Thus, reasons for the delay of milk fat depression by trans-10,cis-12 CLA with the onset of lactation are not clear. Milk protein content decreased with time, but was not affected by CLA feeding in the current study, which is in agreement with previous findings (Castañeda-Gutiérrez et al., 2005; Pappritz et al., 2011) .
Cows fed CLA in the current study showed higher milk production after 5 wk postpartum. The delay in CLA-related stimulation of milk production was probably associated with the described delay in milk fat depression during early lactation, as discussed above, but the distinctiveness of the milk production increment in CLA-fed cows was surprising. Although no differences in plasma NEFA and BHBA concentrations could be observed, the calculated energy balance during CLA supplementation was more negative in CLA than in Ctrl-fed cows due to slightly lower DMI in Pappritz et al., 2011; von Soosten et al., 2011) , stimulating (Shingfield et al., 2004) , as well as no effects (Perfield et al., 2002; Bernal-Santos et al., 2003; Castañeda-Gutiérrez et al., 2005; Odens et al., 2007; von Soosten et al., 2011) on DMI were reported. In addition, CLA feeding in dairy cows was shown to alleviate (Shingfield et al., 2004; Odens et al., 2007) , as well as exacerbate (Pappritz et al., 2011) , postpartum negative energy balance, whereas others reported no effect (Bernal-Santos et al., 2003; Selberg et al., 2004; Castañeda-Gutiérrez et al., 2005; Moallem et al., 2010) . This variation in DMI and calculated energy balance due to CLA feeding might depend on study design (e.g., the amounts of trans-10,cis-12 CLA isomer fed or stage of lactation when CLA feeding was initiated) but suggests that CLA supplementation may not necessarily result in an improved energy status in dairy cows during early lactation. However, calculations of energy balance do not consider CLA effects on body composition, presumably via reduced fat mobilization or on inflammatory status that may result in changes of maintenance requirements and an improved tissue energy level after CLA supplementation (Shingfield et al., 2004; Trevisi et al., 2008; von Soosten et al., 2012) . 1 Samples were collected from wk 2 before parturition to wk 9 of lactation (supplementation period) and from wk 10 to wk 12 of lactation (depletion period) from cows supplemented with CLA and control (Ctrl) fat, fed from 2 wk before parturition up to wk 9 of lactation. Table 6 . Effect of conjugated linoleic acid (CLA) supplementation from 2 wk before parturition to wk 9 of lactation on endogenous glucose production (eGP) and glucose oxidation (GOx) as well as plasma concentrations of glucose and insulin during glucose tolerance test (GTT) in wk 3 and wk 9 of lactation 1,2 Samples were collected in wk 3 and wk 9 of lactation from cows supplemented with CLA and control (Ctrl) fat, fed from 2 wk before parturition up to wk 9 of lactation.
2
Values are least squares means and pooled SEM, n = 10 per group.
3 eGP = endogenous glucose production; GOx = glucose oxidation; GTT = glucose tolerance test; AUC gluc (0-120) was calculated to estimate glucose disposal and AUC ins (0-120) to estimate insulin response after intravenous injection of 1 g/kg 0.75 of glucose. *Different from control (P < 0.05). Samples were collected in wk 3 and wk 9 of lactation from cows supplemented with CLA and control fat (Ctrl), fed from 2 wk before parturition up to wk 9 of lactation. 
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CLA Effects on Glucose Metabolism
The rate of eGP measured in Ctrl-fed cows in wk 3 of lactation was in line with data published earlier (Knowlton et al., 1998) , and eGP corresponded well to the level of milk production (Aschenbach et al., 2010) . Endogenous glucose production increased with ongoing lactation in both groups, supporting the concept of increased eGP with increased DMI in ruminants (Bell and Bauman, 1997; Brockman, 2005; Aschenbach et al., 2010) . The amount of available glucose is important to achieve the full genetic potential for milk production, because lactose is the major osmoregulator for mammary uptake of water (Linzell, 1972; Danfaer, 1994; Rigout et al., 2002) .
Although plasma glucose concentrations were higher during early lactation in CLA-fed than Ctrl-fed cows, eGP in wk 3 of lactation was lower in CLA-fed cows. Probably, decreased eGP and elevated plasma glucose concentrations reflect the reduced glucose need (e.g., for milk fat synthesis) but could additionally result from a more efficient use of metabolizable energy in CLA-fed cows (Voigt et al., 2005; von Soosten et al., 2012) . Ruminants mainly use acetate and butyrate as substrates for FA synthesis, but glucose is needed for milk fat synthesis in ruminants as well to provide NADPH for de novo FA synthesis and glycerol (Palmquist and Jenkins, 1980; Grummer and Carroll, 1991; Bauman and Griinari, 2003; Voigt et al., 2005) . On the other hand, lactose output increased with CLA feeding, as more glucose was available for lactose synthesis, despite eGP reduction in CLA-fed cows. We assume a higher lactose synthesis due to higher glucose availability because of less glucose use for milk fat synthesis in CLA-fed cows and therefore a greater milk yield in CLA-fed cows (Linzell, 1972; Danfaer, 1994; Rigout et al., 2002) . In contrast to long-chain FA in rumen-protected fat, the trans-10,cis-12 CLA isomer inhibits milk fat synthesis in the mammary gland, resulting in a reduced milk fat content; whereas rumen-protected long-chain FA feeding did not inhibit milk fat content, but reduced de novo FA synthesis and increased milk fat synthesis from long-chain FA (Grummer and Carroll, 1991; Bauman et al., 2008) .
In addition, recent findings on tissue mobilization and protein accretion in CLA-fed cows point to a more efficient use of metabolizable energy due to CLA supplementation during early lactation. Indeed, when we calculated the overall glucose sparing in the mammary gland we determined about 122 g of glucose/d due to less glycerol and FA synthesis, but an additional use of glucose for lactose production in CLA-fed cows of about 77 g of glucose/d, resulting in an overall glucose-sparing effect in the mammary gland of about 45 g of glucose/d (for a cow with BW of 600 kg). Because the overall eGP reduction in CLA-fed cows compared with Ctrl-fed cows was 311 g of glucose/d (600 kg BW during 9 wk of lactation), more glucose sparing probably occurred in tissues other than the mammary gland. The additional glucose sparing might result from the improved feed efficiency in CLA-fed cows (von Soosten et al., 2012) , which may lead to reduced whole-body glucose use. Therefore, the reduced eGP in CLA-fed cows might be a consequence of reduced fat synthesis in the mammary gland, but also a result of a more efficient use of metabolizable energy.
The decreased glucose demand may have caused higher plasma glucose concentrations in our study and, at the same time, decreased the need for eGP to retain glucose homeostasis. This is in contrast to feeding of rumen-protected fat, where plasma glucose concentrations decreased, but eGP was unchanged (Hammon et al., 2008) . The slightly lower DMI in CLA-fed cows probably contributed to the decreased eGP observed in our study, likely caused by lower propionate availability in CLA-fed cows (Aschenbach et al., 2010) . The decreasing effect of CLA feeding on eGP was less distinct in wk 9 than in wk 3 of lactation, suggesting differences in eGP regulation with ongoing lactation that were probably related to increased gluconeogenesis from propionate due to increased DMI in both groups (Bell and Bauman, 1997; Brockman, 2005; Aschenbach et al., 2010) .
With the onset of lactation, GOx decreases dramatically in dairy cows, because cows reduce GOx in muscle and fat tissue during early lactation to provide sufficient glucose for milk synthesis (Danfaer, 1994; Bell and Bauman, 1997) . Furthermore, GOx is inversely correlated to milk production . The GOx obtained in the present study supports previous measurements (Hammon et al., 2008) , and the increasing rate of GOx with lactation is in line with increasing eGP and glucose availability (Danfaer, 1994; Bell and Bauman, 1997) . Glucose oxidation was numerically lower in CLA-than Ctrl-fed cows, which seems to support the hypothesis of lower glucose use in CLA-fed cows. The reasons why we did not see a more distinct reduction of GOx in CLA-fed cows are not known. Because GOx is low during early lactation, a more distinct reduction by CLA feeding may occur in mid-lactation cows. In addition, although we have not seen different glycogen concentrations in liver between CLA-and Ctrl-fed cows, glucose was probably used for glycogen synthesis in muscle to refill glycogen depots that were degraded with onset of lactation as we have previously demonstrated (Kuhla et al., 2011) . Elevated plasma glucose concentrations, but reduced eGP in CLA-fed cows might not be a consequence of impaired insulin action. Based on basal plasma insulin concentrations and GTT results, an insulin resistance due to CLA feeding could be excluded in our study, which supports previous findings (Baumgard et al., 2002; Bauman et al., 2008) . Insulin resistance is known from rodents fed diets high in CLA, but those doses were substantially higher than that fed to dairy cows in the present study (Winzell et al., 2006) . In addition, insulin response is less sensitive in the liver compared with other tissues, such as skeletal muscle and fat (Vernon, 2005) , and insulin might be not responsible for the decreased eGP in CLA-fed cows. This assumption is further supported by the lack of difference in plasma glucagon and the glucagon to insulin ratio between groups. Therefore, reduced eGP might be a result of autoregulation (Danfaer, 1994; Brockman, 2005) , although the regulation of eGP by glucokinase activity may be less pronounced in ruminants (Moore et al., 1998; Tappy et al., 2000) .
The mRNA concentrations of PEPCKc and G6Pase tended to be reduced in CLA-fed cows, which supports the overall finding of reduced eGP. In a previous study, CLA supplementation did not affect hepatic mRNA of PC and PEPCKc in dairy cows during early lactation (Selberg et al., 2004) , but rumen-protected fat supplementation resulted in decreased G6Pase mRNA concentrations in liver (Lohrenz et al., 2010) . As supplementation of trans-10,cis-12 CLA, as well as rumen-protected fat, results in a glucose-sparing effect, hepatic gene expression of G6Pase might be a key factor in regulating eGP by reducing glucose delivery to the circulation. Interestingly, CLA treatment decreased gluconeogenesis in porcine hepatocytes, possibly due to increased hepatic insulin sensitivity (Conde-Aguilera et al., 2012) . However, it is not clear whether this is also the case in bovine hepatocytes, and, as discussed above, CLA may have not changed insulin sensitivity in our study. Conversely, CLA feeding did not affect CPT1 mRNA concentrations in liver. The CPT1 mRNA codes for a key enzyme-initiating hepatic FA oxidation. Therefore, hepatic FA oxidation was probably not affected by CLA feeding in line with the lack of difference in liver fat concentrations.
CONCLUSIONS
In conclusion, our data show reduced eGP in dairy cows supplemented with CLA containing the trans-10,cis-12 isomer. Diminished eGP was associated with decreased milk fat yield, but partially elevated milk production and a more negative energy balance during early lactation. Although CLA supplementation did not result in improved energy status, more glucose was excreted in the milk, but less glucose was used in the mammary gland and probably also in other tissues, indicating a glucose-sparing effect in CLA-fed cows. The decreased glucose use was counterbalanced by reduced eGP to retain glucose homeostasis and enable a more efficient milk production.
